193 related articles for article (PubMed ID: 18930950)
1. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.
Shaw PJ; Ditewig AC; Waring JF; Liguori MJ; Blomme EA; Ganey PE; Roth RA
Toxicol Sci; 2009 Jan; 107(1):270-80. PubMed ID: 18930950
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
Shaw PJ; Hopfensperger MJ; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):259-66. PubMed ID: 17709330
[TBL] [Abstract][Full Text] [Related]
3. The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability.
Shaw PJ; Fullerton AM; Scott MA; Ganey PE; Roth RA
Toxicol Appl Pharmacol; 2009 May; 236(3):293-300. PubMed ID: 19367693
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jan; 328(1):62-8. PubMed ID: 18820134
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils.
Waring JF; Liguori MJ; Luyendyk JP; Maddox JF; Ganey PE; Stachlewitz RF; North C; Blomme EA; Roth RA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1080-7. PubMed ID: 16299187
[TBL] [Abstract][Full Text] [Related]
6. Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jul; 330(1):72-8. PubMed ID: 19351866
[TBL] [Abstract][Full Text] [Related]
7. Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice.
Giustarini G; Kruijssen L; van Roest M; Bleumink R; Weaver RJ; Bol-Schoenmakers M; Smit J; Pieters R
J Appl Toxicol; 2018 May; 38(5):753-765. PubMed ID: 29377180
[TBL] [Abstract][Full Text] [Related]
8. Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related.
Beggs KM; Maiuri AR; Fullerton AM; Poulsen KL; Breier AB; Ganey PE; Roth RA
Toxicology; 2015 May; 331():35-46. PubMed ID: 25748550
[TBL] [Abstract][Full Text] [Related]
9. Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.
Poulsen KL; Albee RP; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2014 May; 349(2):185-91. PubMed ID: 24525298
[TBL] [Abstract][Full Text] [Related]
10. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity.
Shaw PJ; Beggs KM; Sparkenbaugh EM; Dugan CM; Ganey PE; Roth RA
Toxicol Sci; 2009 Oct; 111(2):288-301. PubMed ID: 19638433
[TBL] [Abstract][Full Text] [Related]
11. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.
Giustarini G; Huppelschoten S; Barra M; Oppelt A; Wagenaar L; Weaver RJ; Bol-Schoenmakers M; Smit JJ; van de Water B; Klingmüller U; Pieters RHH
Toxicol Appl Pharmacol; 2020 Mar; 391():114915. PubMed ID: 32035082
[TBL] [Abstract][Full Text] [Related]
12. Comparison of TNFα to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: Trovafloxacin as an example.
Liguori MJ; Ditewig AC; Maddox JF; Luyendyk JP; Lehman-McKeeman LD; Nelson DM; Bhaskaran VM; Waring JF; Ganey PE; Roth RA; Blomme EA
Int J Mol Sci; 2010 Nov; 11(11):4697-714. PubMed ID: 21151465
[TBL] [Abstract][Full Text] [Related]
13. TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.
Ahn JH; Jegal H; Choi MS; Kim S; Park SM; Ahn J; Han HY; Cho HS; Yoon S; Oh JH
Toxicol Lett; 2021 May; 342():73-84. PubMed ID: 33609687
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.
Beggs KM; Fullerton AM; Miyakawa K; Ganey PE; Roth RA
Toxicol Sci; 2014 Jan; 137(1):91-101. PubMed ID: 24097668
[TBL] [Abstract][Full Text] [Related]
15. The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
Shimizu Y; Margenthaler JA; Landeros K; Otomo N; Doherty G; Flye MW
Hepatology; 2002 Apr; 35(4):805-14. PubMed ID: 11915026
[TBL] [Abstract][Full Text] [Related]
16. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
17. Trovafloxacin enhances lipopolysaccharide-stimulated production of tumor necrosis factor-α by macrophages: role of the DNA damage response.
Poulsen KL; Olivero-Verbel J; Beggs KM; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2014 Jul; 350(1):164-70. PubMed ID: 24817034
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with granulocyte-colony stimulating factor decreases lipopolysaccharide-induced interferon-gamma production in mice in association with the production of interleukin-18.
Shaklee CL; Guo J; Faggioni R; Fantuzzi G; Senaldi G
Cytokine; 2004 Feb; 25(3):119-26. PubMed ID: 14698138
[TBL] [Abstract][Full Text] [Related]
19. Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction.
Hsiao CJ; Younis H; Boelsterli UA
Chem Biol Interact; 2010 Oct; 188(1):204-13. PubMed ID: 20655887
[TBL] [Abstract][Full Text] [Related]
20. Trovafloxacin-Induced Liver Injury: Lack in Regulation of Inflammation by Inhibition of Nucleotide Release and Neutrophil Movement.
Giustarini G; Vrisekoop N; Kruijssen L; Wagenaar L; van Staveren S; van Roest M; Bleumink R; Bol-Schoenmakers M; Weaver RJ; Koenderman L; Smit J; Pieters R
Toxicol Sci; 2019 Feb; 167(2):385-396. PubMed ID: 30247740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
